HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Songul Serefhanoglu Selected Research
Songul Serefhanoglu Research Topics
Disease
3
Leukemia
12/2013 - 03/2009
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2013 - 04/2009
2
Fever (Fevers)
01/2010 - 10/2008
1
Lymphoma (Lymphomas)
01/2022
1
Pathologic Complete Response
01/2022
1
Aplastic Anemia (Anemia, Hypoplastic)
01/2011
1
Body Weight (Weight, Body)
12/2010
1
Diarrhea
12/2010
1
Weight Loss (Weight Reduction)
12/2010
1
Acute Promyelocytic Leukemia
12/2010
1
Autoimmune Diseases (Autoimmune Disease)
09/2010
1
Hypotension (Low Blood Pressure)
01/2010
1
Syncope (Fainting)
01/2010
1
Myeloid Sarcoma (Chloroma)
01/2010
1
Systemic Mastocytosis
01/2010
1
Multiple Organ Failure (MODS)
04/2009
1
Periapical Abscess
10/2008
1
Pulmonary Embolism
10/2008
1
Anemia
05/2008
1
Cerebrovascular Disorders (Cerebrovascular Occlusion)
05/2008
1
Hyperhomocysteinemia
05/2008
1
Stroke (Strokes)
05/2008
Drug/Important Bio-Agent (IBA)
1
Carmustine (FIVB)
FDA Link
01/2022
1
Mitoxantrone (Novantrone)
FDA Link
Generic
01/2022
1
Etoposide (VP 16)
FDA Link
Generic
01/2022
1
Melphalan (Alkeran)
FDA Link
Generic
01/2022
1
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
01/2011
1
Globulins
IBA
01/2011
1
Thomsen-Friedenreich antibodies
IBA
01/2011
1
Carcinoembryonic Antigen
IBA
12/2010
1
Hemoglobins (Hemoglobin)
IBA
12/2010
1
Anthracyclines
IBA
12/2010
1
Autoantigens
IBA
09/2010
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2010
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2010
1
HLA-DR Antigens (HLA-DR)
IBA
04/2009
1
Anti-Bacterial Agents (Antibiotics)
IBA
10/2008
1
Vitamin B 12 (Cyanocobalamin)
FDA Link
Generic
05/2008
1
Homocysteine
IBA
05/2008
1
Indicators and Reagents (Reagents)
IBA
05/2008
Therapy/Procedure
5
Drug Therapy (Chemotherapy)
01/2022 - 03/2009
3
Therapeutics
01/2022 - 10/2008
2
Hematopoietic Stem Cell Transplantation
01/2022 - 12/2013
1
BEAM regimen
01/2022
1
CCG-141 protocol
12/2010